Cardiac troponin I for stratification of early outcomes and the efficacy of enoxaparin in unstable angina: a TIMI-11B substudy.

@article{Morrow2000CardiacTI,
  title={Cardiac troponin I for stratification of early outcomes and the efficacy of enoxaparin in unstable angina: a TIMI-11B substudy.},
  author={David A. Morrow and Elliott Marshall Antman and Milenko Tanasijevic and N M El Rifai and James A. de Lemos and Carolyn H. McCabe and Christopher Paul Cannon and Eugene Braunwald},
  journal={Journal of the American College of Cardiology},
  year={2000},
  volume={36 6},
  pages={1812-7}
}
OBJECTIVES We sought to evaluate cardiac troponin I (cTnI) for predicting early clinical outcomes and the efficacy of enoxaparin among patients with non-ST segment elevation acute coronary syndrome (ACS) and negative creatine kinase, MB fraction (CK-MB) levels. BACKGROUND Cardiac TnI identifies patients with unstable angina who are at higher risk of death or myocardial infarction (MI) by 30 days. The utility of cTnI for predicting very early clinical events, including recurrent ischemia, and… CONTINUE READING